SEC Form 4 · accession 0001651844-18-000016
NYMOX PHARMACEUTICAL CORP · NYMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James George Robinson
Director
Period of report
Oct 25, 2018
Accepted (ET)
Oct 26, 2018 · 11:47 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001018735
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 25, 2018 | P | 400 | $1.59 | A | 3,168,950 | D | |
| Common Stock | Oct 25, 2018 | P | 510 | $1.60 | A | 3,169,460 | D | |
| Common Stock | Oct 25, 2018 | P | 600 | $1.605 | A | 3,170,060 | D | |
| Common Stock | Oct 25, 2018 | P | 1,090 | $1.61 | A | 3,171,150 | D | |
| Common Stock | Oct 25, 2018 | P | 700 | $1.62 | A | 3,171,850 | D | |
| Common Stock | Oct 25, 2018 | P | 6,700 | $1.63 | A | 3,178,550 | D |
Table II — derivative securities
No Table II lines on this filing.